Clinical Trials Directory

Trials / Completed

CompletedNCT06410742

The Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome

Exploring the Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome: a Cross-Sectional Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Kahramanmaras Sutcu Imam University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and treatment management, the evaluations will be performed once by the researchers and will take approximately one hour. In addition, healthy individuals with a similar average age to the evaluation group without any disease diagnosis will be included in the study as a control group. Evaluations of the healthy group will be made once by the researchers and will take approximately one hour. Data will be collected face to face at the Faculty of Physical Therapy and Rehabilitation, Rheumatology Unit. Data collection tool of the research: * Information about patients will be recorded with the Demographic Information Form. * EULAR Sjögren's Syndrome Disease Activity Index * EULAR Sjögren's Syndrome Patient Reporting Index * Primary Sjögren's Syndrome Quality of Life Scale * BETY-Biopsychosocial Questionnaire * Central Sensitization Scale * Pain Catastrophizing Scale * Hospital Anxiety and Depression Scale * Multidimensional Fatigue Rating Scale * Turkish Eating Assessment Tool * Yale Swallow Protocol * Test of Mastication and Swallowing Solids * Dysphagia Limit Test * Xerostomia inventory

Conditions

Timeline

Start date
2024-06-19
Primary completion
2024-12-30
Completion
2025-01-01
First posted
2024-05-13
Last updated
2025-02-28

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06410742. Inclusion in this directory is not an endorsement.